Cargando…
Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer
Oral fluoropyrimidine anticancer agents (oral 5-fluorouracil [5-FU]) able to be used as chemotherapy for breast cancer include tegafur–uracil (UFT), tegafur–gimeracil–oteracil potassium (S-1), doxifluridine, and capecitabine. Since the 1980s, UFT has been most widely used for postoperative chemother...
Autor principal: | Watanabe, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824200/ https://www.ncbi.nlm.nih.gov/pubmed/23456736 http://dx.doi.org/10.1007/s12282-013-0451-9 |
Ejemplares similares
-
An overview of the Japan Breast Cancer Research Group (JBCRG) activities
por: Ohno, Shinji, et al.
Publicado: (2013) -
Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022) -
Fertility preservation in breast cancer patients
por: Shien, Tadahiko, et al.
Publicado: (2013) -
Activities and Health Status of Dispatched Public Health Nurses after the Great East Japan Earthquake
por: Yokoyama, Yoshie, et al.
Publicado: (2014) -
The Japan Society of Ultrasonics in Medicine guidelines on non-mass abnormalities of the breast
por: Ito, Toshikazu, et al.
Publicado: (2023)